Impact of MBL and MASP-2 gene polymorphism and its interaction on susceptibility to tuberculosis

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Chen, Mengshi ^a,b   Liang, Ying ^a,c   Li, Wufei ^d   Wang, Mian ^a   Hu, Li ^a,e   Abuaku, Benjamin Kwaku ^a,f   Huang, Xin ^a   Tan, Hongzhuan ^a   Wen, Shi Wu ^a,g  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN CHILDREN'S HOSPITAL   (China)

^c XINJIANG MEDICAL UNIVERSITY   (China)

^d Shaoyang Medical College   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f University of Ghana   (Ghana)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Gene; Interaction; MASP 2; MBL; RERI; Tuberculosis

Indexed keywords

MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEASE 2; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG; GENETIC MARKER; MASP2 PROTEIN, HUMAN;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE; GENE INTERACTION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFECTION SENSITIVITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASP 2 GENE; MBL GENE; PROMOTER REGION; TUBERCULOSIS; CHINA; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; STATISTICAL MODEL;

CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; POLYMORPHISM, GENETIC; TUBERCULOSIS;

EID: 84927936532     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0879-y     Document Type: Article

References (37)

1. The Technical Guidance Group of the Fifth National TB Epidemiological Survey. The Fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberc. 2012;34(08):485-508. in Chinese.
2. Ducati RG, Ruffino-Netto A, Basso LA, Santos DS. The resumption of consumption - a review on tuberculosis. Mem Inst Oswaldo Cruz. 2006;101(7):697-714.
3. Narasimhan P, Wood J, Macintyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med. 2013;2013:828939.
4. Liu J, Yan J, Wan Q, Ye Q, Huang Y. The risk factors for tuberculosis in liver or kidney transplant recipients. BMC Infect Dis. 2014;14:387.
5. Rajaram MV, Ni B, Dodd CE, Schlesinger LS. Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol. 2014;26(6):471-85.
6. Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun. 2012;80(10):3343-59.
7. Guo C, Zhang H, Gao Q, He D, Tang M, Liu S, et al. Monocyte chemoattractant protein-1 in spinal tuberculosis: -362G/C genetic variant and protein levels in Chinese patients. Diagn Microbiol Infect Dis. 2014;78(1):49-52.
8. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today. 1996;17(11):532-40.
9. Matsushita M, Endo Y, Fujita T. Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol. 2000;164(5):2281-4.
10. Sato T, Endo Y, Matsushita M, Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol. 1994;6(4):665-9.
11. Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol. 2003;21:547-78.
12. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 1995;155(6):3013-20.
13. Boldt AB, Petzl-Erler ML. A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat. 2002;19(3):296-306.
14. Heitzeneder S, Seidel M, Forster-Waldl E, Heitger A. Mannan-binding lectin deficiency - Good news, bad news, doesn't matter? Clin Immunol. 2012;143(1):22-38.
15. Thiel S, Steffensen R, Christensen IJ, Ip WK, Lau YL, Reason IJ, et al. Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun. 2007;8(2):154-63.
16. Thiel S, Kolev M, Degn S, Steffensen R, Hansen AG, Ruseva M, et al. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity. J Immunol. 2009;182(5):2939-47.
17. Capparelli R, Iannaccone M, Palumbo D, Medaglia C, Moscariello E, Russo A, et al. Role played by human mannose-binding lectin polymorphisms in pulmonary tuberculosis. J Infect Dis. 2009;199(5):666-72.
18. Soborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis. 2003;188(5):777-82.
19. Selvaraj P, Jawahar MS, Rajeswari DN, Alagarasu K, Vidyarani M, Narayanan PR. Role of mannose binding lectin gene variants on its protein levels and macrophage phagocytosis with live Mycobacterium tuberculosis in pulmonary tuberculosis. FEMS Immunol Med Microbiol. 2006;46(3):433-7.
20. Liu W, Zhang F, Xin ZT, Zhao QM, Wu XM, Zhang PH, et al. Sequence variations in the MBL gene and their relationship to pulmonary tuberculosis in the Chinese Han population. Int J Tuberc Lung Dis. 2006;10(10):1098-103.
21. Shi J, Xie M, Wang JM, Xu YJ, Xiong WN, Liu XS. Mannose-binding lectin two gene polymorphisms and tuberculosis susceptibility in Chinese population: a meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2013;33(2):166-71.
22. da Cruz HL, da Silva RC, Segat L, de Carvalho MS, Brandao LA, Guimaraes RL, et al. MBL2 gene polymorphisms and susceptibility to tuberculosis in a northeastern Brazilian population. Infect Genet Evol. 2013;19:323-9.
23. You HL, Lin TM, Wang JC, Li CC, Chao TL, Liao WT, et al. Mannose-binding lectin gene polymorphisms and mycobacterial lymphadenitis in young patients. Pediatr Infect Dis J. 2013;32(9):1005-9.
24. Vasconcelos LR, Fonseca JP, DoCarmo RF, de Mendonca TF, Pereira VR, Lucena-Silva N, et al. Mannose-binding lectin serum levels in patients with leprosy are influenced by age and MBL2 genotypes. Int J Infect Dis. 2011;15(8):e551-557.
25. Catarino SJ, Boldt AB, Beltrame MH, Nisihara RM, Schafranski MD, de Messias-Reason IJ. Association of MASP2 polymorphisms and protein levels with rheumatic fever and rheumatic heart disease. Hum Immunol. 2014;75(12):1197-202.
26. Sorensen GL, Petersen I, Thiel S, Fenger M, Christensen K, Kyvik KO, et al. Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity. Genet Epidemiol. 2007;31(1):31-41.
27. Boldt AB, Luz PR, Messias-Reason IJ. MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clin Immunol. 2011;140(1):63-70.
28. Sorensen R, Thiel S, Jensenius JC. Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol. 2005;27(3):299-319.
29. Tulio S, Faucz FR, Werneck RI, Olandoski M, Alexandre RB, Boldt AB, et al. MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection. Hum Immunol. 2011;72(10):912-5.
30. Ministry of Health of China. Diagnostic criteria for pulmonary tuberculosis (WS288-2008). Ministry of Health of China; 2008. Available at http://www.nhfpc.gov.cn/zwgkzt/s9491/wsbz_2.shtml
31. Chen M, Kwaku AB, Chen Y, Huang X, Tan H, Wen SW. Gender and regional disparities of tuberculosis in Hunan, China. Int J Equity Health. 2014;13:32.
32. VanderWeele TJ, Vansteelandt S. A weighting approach to causal effects and additive interaction in case-control studies: marginal structural linear odds models. Am J Epidemiol. 2011;174(10):1197-203.
33. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol. 2003;40(7):423-9.
34. Denholm JT, McBryde ES, Eisen DP. Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis. Clin Exp Immunol. 2010;162(1):84-90.
35. Wang Y, Yan J, Shi Y, Li P, Liu C, Ma Q, et al. Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection. BMC Infect Dis. 2009;9:51.
36. Le Hir H, Nott A, Moore MJ. How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci. 2003;28(4):215-20.
37. Niu DK, Yang YF. Why eukaryotic cells use introns to enhance gene expression: Splicing reduces transcription-associated mutagenesis by inhibiting topoisomerase I cutting activity. Biol Direct. 2011;6:24.